Retatrutide: What It May Change and What Can Go Wrong
People's accounts are kept apart from the side effects found in Phase 2 studies, so you can see which is which.
What the studies proved and what that means for you
Which changes did researchers measure? Which ones come only from what people said? Retatrutide remains in Phase 3, the large late-stage tests, and isn't approved anywhere.
Some people use unregulated products outside a study and then describe what they felt. You can't use their words to confirm what was in the vial or how much entered the body.
Phase 2, an earlier study stage, found lower sugar, weight, and liver fat. Nausea rose with the amount used, and heart rate went up a little.
Outside studies, people often mention less hunger, fast weight loss, and early stomach trouble. As you read, personal claims come first, followed by harm that study teams measured.
What people say retatrutide did and what you can trust
The notes below are personal accounts from research use. A controlled study did not produce them, and a trial hasn't tested whether the claims are true.
No one confirmed the amounts in these accounts. What happens to you may differ a great deal.
Changes people liked
Hunger eased and food thoughts faded (often reported): Food, they say, quit taking over the day. You may hear this called "food noise going quiet," even when the person doesn't feel full.
Fast and marked weight loss (often reported): Some people describe faster weight loss than they felt on GLP-1 drugs, which copy a hunger hormone. The scale often fell during the early weeks, but these accounts don't prove the Phase 2 trend.
Feeling warmer or sweating more (often reported): Some users felt warm, flushed, or quick to sweat. They think glucagon may be involved because that hormone can raise your body's energy use.
Feeling calmer about food (sometimes reported): Some users said eating caused less worry and cravings bothered them less. They guessed GLP-1, a hunger hormone, played a part, but a study has not shown that the drug caused it.
Changes people disliked
Nausea after a shot or a larger amount (often reported): Many accounts mention a sick stomach after the needle. They place the worst point 4–8 hours later and say it eased as the first weeks passed.
A faster pulse at rest (often reported): After a shot, some users became very aware of each heartbeat. Watches in their accounts showed 5–15 beats per minute rises. Phase 2 also found a faster heart rate, but in a different group [1].
Sulfur-smelling burps (often reported): Food seemed to sit in the stomach for longer. Users blame GLP-1, the hunger hormone, and many say the burps later eased.
Tiredness early on (often reported): Heavy legs, extra sleep, and a foggy feeling followed some shots. Users often blamed a steep drop in food, but no study tested that cause.
Constipation (often reported): Some accounts mention eating less and passing stool less often. Users also thought the hunger-hormone effect slowed their stomach and bowels.
Muscles feeling softer as weight fell (sometimes reported): A softer feel came with weight loss in some accounts. In Phase 2, muscle fell along with fat [4].
Itching or redness near the needle mark (sometimes reported): A small patch sometimes looked red or felt itchy. Users said it cleared within 24–48 hours; studies found such reactions in about 8% of Phase 2 participants [1].
Poor sleep (sometimes reported): Some users lay awake or woke during the night. They blamed the glucagon effect for keeping their bodies active, but the cause isn't known.
What retatrutide side effects could mean for you
Phase 2 studies found a faster pulse along with stomach and bowel trouble. At higher amounts, people had both problems more often, which matters for your risk.
- The Phase 2 obesity study found nausea in up to 45% of people at its highest amount. It chiefly drove the 18% stop rate there [1].
- Vomiting, diarrhea, and constipation increased with the amount used [1][2].
- The top amounts raised heart rate about 5–7 beats per minute. Near week 24, that rise reached its top point and may come from glucagon [1].
- Skin reactions near the needle affected about 8% in Phase 2 [1].
- Burning, tingling, or other odd skin feelings have appeared with drugs that work on the hunger hormone [13].
In the type 2 diabetes study, researchers recorded neither death nor a severe sugar drop at doses up to 12 mg [2]. Those Phase 2 studies still can't show your long-term risk.
What can put your health at risk
The label on a vial may be wrong [1]
In mid-2026, retatrutide lacked FDA approval and wasn't a prescription product. The bottle could hold germs, a different drug, or a strength the label doesn't show.
Tests of similar products have found broken-down drug, unwanted changes in the drug, or another drug. A dirty needle can lead to sepsis. That infection can set off a deadly response throughout your body.
The FDA sent over 50 seller warnings about retatrutide in 2025 because they broke federal drug law [1]. That action doesn't make any unapproved vial safe for you.
More stomach trouble at higher amounts [1][2][4]
At the largest amount, nausea reached as many as 45% in the Phase 2 obesity study. It caused an 18% stop rate at that level.
The GLP-1 hunger-hormone effect may keep a meal in your stomach longer and slow the bowel. Without study staff nearby, too much vomiting or diarrhea can leave you short of water and body salt [1].
A faster heart rate and unknown heart risk [1].
With the highest amounts, the Phase 2 rise was about 5–7 beats per minute, peaking near 24 weeks. Glucagon may speed the heart, though researchers don't know the full process.
The heart and kidney study hasn't shown whether this causes rhythm trouble or heart damage [1][10]. You still lack a clear answer about long-term heart risk.
Insulin or diabetes pills may drive sugar too low [2]
Retatrutide's GLP-1 and GIP effects help insulin enter the blood when sugar climbs. That effect can grow when insulin or certain diabetes pills are added, making blood sugar sink too far.
People who entered the Phase 2 diabetes study on insulin used a smaller amount. Without medical care, a severe blood-sugar drop is a real risk [2].
Fast loss can weaken your muscles too [4]
A 2025 study found that retatrutide reduced muscle as well as fat. Older surgery reports showed a larger muscle share, but people taking retatrutide still lost muscle [4].
For you, muscle loss matters even more with age or if your muscles are already weak. Less muscle can make your daily work and balance harder.
Long-term safety isn't known yet [9][10]
The TRIUMPH Phase 3 heart and kidney studies remained unfinished in mid-2026. You didn't yet have long-term answers from them.
Similar GLP-1 hunger-hormone drugs often show weight returning after people stop them. The kidney study is checking kidney harm, so the answer isn't available to you yet [9][10].